Cargando…

Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort

BACKGROUND: Despite increased antiretroviral therapy (ART) coverage and the raised CD4 threshold for starting ART, opportunistic infections (OIs) are still one of the leading causes of death in sub-Saharan Africa. There are few studies from resource-limited settings on long-term reporting of OIs oth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weissberg, Dana, Mubiru, Frank, Kambugu, Andrew, Fehr, Jan, Kiragga, Agnes, von Braun, Amrei, Baumann, Anna, Kaelin, Marisa, Sekaggya-Wiltshire, Christine, Kamya, Moses, Castelnuovo, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211746/ https://www.ncbi.nlm.nih.gov/pubmed/30383836 http://dx.doi.org/10.1371/journal.pone.0206796

Ejemplares similares

Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy
por: Flynn, Andrew G., et al.
Publicado: (2017)

Early virological failure and HIV drug resistance in Ugandan adults co-infected with tuberculosis
por: von Braun, Amrei, et al.
Publicado: (2017)

A decade of antiretroviral therapy in Uganda: what are the emerging causes of death?
por: Kiragga, Agnes N., et al.
Publicado: (2019)

First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2016)

Outcomes in a Cohort of Patients Started on Antiretroviral Treatment and Followed up for a Decade in an Urban Clinic in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2015)

Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis
por: Kwizera, Richard, et al.
Publicado: (2017)

‘Out of sight, out of mind?’ A follow-up on HIV-infected patients with drug-resistant pulmonary tuberculosis in Uganda: A case series
por: Notarfrancesco, Marco, et al.
Publicado: (2021)

Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study
por: Sekaggya-Wiltshire, Christine, et al.
Publicado: (2017)

Antiretroviral concentration measurements as an additional tool to manage virologic failure in resource limited settings: a case control study
por: Buzibye, Allan, et al.
Publicado: (2019)

Antiretroviral treatment Long-Term (ALT) cohort: a prospective cohort of 10 years of ART-experienced patients in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2018)

Evaluation of WHO Criteria for Viral Failure in Patients on Antiretroviral Treatment in Resource-Limited Settings
por: Castelnuovo, Barbara, et al.
Publicado: (2011)

Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda
por: Sekaggya Wiltshire, Christine, et al.
Publicado: (2014)

Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on Antiretroviral Therapy (ART) in sub-Saharan Africa: Frequency and clinical significance
por: Nakanjako, Damalie, et al.
Publicado: (2008)

Increasing retention of HIV positive pregnant and breastfeeding mothers on option-b plus by upgrading and providing full time HIV services at a lower health facility in rural Uganda
por: Masereka, Enosk Mirembe, et al.
Publicado: (2019)

Challenges in achieving a target international normalized ratio for deep vein thrombosis among HIV-infected patients with tuberculosis: a case series
por: Sekaggya, C, et al.
Publicado: (2016)

Challenges in Assessing Outcomes among Infants of Pregnant HIV-Positive Women Receiving ART in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2017)

Comparison of different cardiovascular risk tools used in HIV patient cohorts in sub-Saharan Africa; do we need to include laboratory tests?
por: Mubiru, Frank, et al.
Publicado: (2021)

Longitudinal patients' cohorts for impactful research and HIV care at the Infectious Diseases Institute
por: Castelnuovo, Barbara, et al.
Publicado: (2022)

High CD56(++)CD16(-) natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV treatment cohort
por: Bayigga, Lois, et al.
Publicado: (2014)

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
por: Laker, Eva Agnes Odongpiny, et al.
Publicado: (2019)

Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda
por: Nakanjako, Damalie, et al.
Publicado: (2011)

Prospective evaluation of radiographic manifestations of tuberculosis in relationship with CD4 count in patients with HIV/AIDS
por: Frey, Vanessa, et al.
Publicado: (2023)

Reasons for first line ART modification over the years during the ART scale up in Uganda
por: Castelnuovo, B., et al.
Publicado: (2019)

Among Patients with Sustained Viral Suppression in a Resource-Limited Setting, CD4 Gains Are Continuous Although Gender-Based Differences Occur
por: Sempa, Joseph B., et al.
Publicado: (2013)

Adherence monitoring methods to measure virological failure in people living with HIV on long-term antiretroviral therapy in Uganda
por: Okoboi, Stephen, et al.
Publicado: (2022)

Virologic versus immunologic monitoring and the rate of accumulated genotypic resistance to first-line antiretroviral drugs in Uganda
por: Reynolds, Steven J, et al.
Publicado: (2012)

Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings
por: Kiragga, Agnes N, et al.
Publicado: (2010)

Perceptions and Attitudes Toward an Interactive Voice Response Tool (Call for Life Uganda) Providing Adherence Support and Health Information to HIV-Positive Ugandans: Qualitative Study
por: Kajubi, Phoebe, et al.
Publicado: (2022)

Increased uptake of tuberculosis preventive therapy (TPT) among people living with HIV following the 100-days accelerated campaign: A retrospective review of routinely collected data at six urban public health facilities in Uganda
por: Musaazi, Joseph, et al.
Publicado: (2023)

Quantifying retention during pre-antiretroviral treatment in a large urban clinic in Uganda
por: Castelnuovo, Barbara, et al.
Publicado: (2015)

Risky sexual behavior among patients on long-term antiretroviral therapy: a prospective cohort study in urban and rural Uganda
por: Okoboi, Stephen, et al.
Publicado: (2018)

Describing Point of Entry into Care and Being Lost to Program in a Cohort of HIV Positive Pregnant Women in a Large Urban Centre in Uganda
por: Musomba, Rachel, et al.
Publicado: (2017)

A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients
por: Bisaso, Kuteesa R., et al.
Publicado: (2018)

Incident Tuberculosis during Antiretroviral Therapy Contributes to Suboptimal Immune Reconstitution in a Large Urban HIV Clinic in Sub-Saharan Africa
por: Hermans, Sabine M., et al.
Publicado: (2010)

Impact of a mobile phone-based interactive voice response software on tuberculosis treatment outcomes in Uganda (CFL-TB): a protocol for a randomized controlled trial
por: Byonanebye, Dathan Mirembe, et al.
Publicado: (2021)

Baseline Xpert MTB/RIF ct values predict sputum conversion during the intensive phase of anti-TB treatment in HIV infected patients in Kampala, Uganda: a retrospective study
por: Namugenyi, Juliet, et al.
Publicado: (2021)

Clinical pharmacokinetics of antiretroviral drugs in Ugandan patients
por: Lamorde, M
Publicado: (2012)

High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort
por: Nakanjako, Damalie, et al.
Publicado: (2011)

Spectrum of antibiotic resistance in UTI caused by Escherichia coli among HIV-infected patients in Uganda: a cross-sectional study
por: Abongomera, George, et al.
Publicado: (2021)

Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial
por: Nakanjako, Damalie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j8dbnua4o1ojjjc5cchb5k4kk8